T1	Premise 57 171	67-year-old woman diagnosed with an infiltrating ductal carcinoma of the breast and no family history of neoplasia
T2	Claim 276 319	Complete phenotypic study by flow cytometry
T3	Claim 324 359	Study of hormone receptors and HER2
T4	Claim 364 438	Study of hormone receptors, e-cadherin and study of first-degree relatives
T5	Claim 443 493	BRCA 1-2 study and study of first-degree relatives
T6	Claim 520 769	All breast carcinomas should be accompanied by the study of hormone receptors and HER-2 for the prognostic implications of the tumor, as well as the adequacy of the treatment of the same, since depending on the result will apply some drugs or others
T7	Diagnostics 571 607	study of hormone receptors and HER-2
T8	Marker 708 713	since
T9	Claim 771 828	The study of relatives and the BCRA gene is not indicated
T10	Premise 835 882	she does not have a family history of neoplasia
T11	Marker 829 834	since
R1	Support Ent1:T10 Ent2:T9	
R2	Attack Ent1:T9 Ent2:T5	
R3	Support Ent1:T6 Ent2:T2	
T12	Diagnostics 276 319	Complete phenotypic study by flow cytometry
T13	Diagnostics 324 359	Study of hormone receptors and HER2
T14	Diagnostics 364 402	Study of hormone receptors, e-cadherin
T15	Diagnostics 407 438	study of first-degree relatives
T16	Diagnostics 443 457	BRCA 1-2 study
R4	Attack Ent1:T9 Ent2:T4	
T17	Diagnostics 462 493	study of first-degree relatives
